Valuation: PharmaEssentia Corporation

Market Cap 50TCr 1.57TCr 1.37TCr 1.29TCr 1.17TCr 2.2TCr 1,50600Cr 2.21TCr 15TCr 5.97TCr 77TCr 5.89TCr 5.76TCr 2,46300Cr P/E 2026 *
45.4x
P/E 2027 * 28.6x
Enterprise Value 47TCr 1.49TCr 1.3TCr 1.22TCr 1.11TCr 2.08TCr 1,42600Cr 2.09TCr 15TCr 5.65TCr 72TCr 5.58TCr 5.46TCr 2,33200Cr EV / Sales 2026 *
16.7x
EV / Sales 2027 * 11.6x
Free-Float
77.98%
Yield 2026 *
0.33%
Yield 2027 * 0.2%
1 day+2.12%
1 week-5.86%
Current month-13.62%
1 month-12.36%
3 months+26.10%
6 months+108.86%
Current year+184.40%
1 week 1,170
Extreme 1170
1,235
1 month 1,165
Extreme 1165
1,645
Current year 423.7
Extreme 423.699083
1,645
1 year 407.92
Extreme 407.923053
1,645
3 years 228.27
Extreme 228.269713
1,645
5 years 56.05
Extreme 56.051993
1,645
10 years 43.54
Extreme 43.541837
1,645
Manager TitleAgeSince
Chief Executive Officer - 01/01/2017
Director of Finance/CFO - 14/10/2015
President - 25/06/2015
Director TitleAgeSince
Director/Board Member 73 01/05/2024
Director/Board Member - 05/08/2021
Director/Board Member - 27/05/2024
Change 5-day change 1-year change 3-year change Capi.($)
+2.12%-5.86%+161.58%+333.73% 1.57TCr
-0.31%+5.79%+47.13%+99.53% 7.09TCr
-0.57%-0.16%+37.26%+82.94% 6.25TCr
+5.26%+7.86%+32.24%+30.06% 2.63TCr
-3.21%-7.27%-17.10%+370.22% 2.62TCr
-2.64%-0.69%-0.17%-11.56% 2.41TCr
-0.73%+6.14%+23.71%-11.99% 2.07TCr
-0.22%+3.99%+45.54%+171.32% 1.45TCr
+0.73%+1.71%-5.51%+859.68% 1.42TCr
+7.37%+2.99%-5.69%+520.28% 1.41TCr
Average +0.78%+1.49%+31.90%+244.42% 2.89TCr
Weighted average by Cap. +0.21%+1.38%+33.17%+171.07%

Financials

2026 *2027 *
Net sales 2.83TCr 89Cr 78Cr 73Cr 67Cr 124.68Cr 8.54TCr 125.2Cr 877.83Cr 338.75Cr 4.34TCr 334.35Cr 326.92Cr 14TCr 4.01TCr 125.86Cr 109.75Cr 103.63Cr 94Cr 176.31Cr 12TCr 177.05Cr 1.24TCr 479.03Cr 6.14TCr 472.8Cr 462.31Cr 20TCr
Net income 1.1TCr 35Cr 30Cr 29Cr 26Cr 49Cr 3.32TCr 49Cr 341.54Cr 131.8Cr 1.69TCr 130.08Cr 127.2Cr 5.44TCr 1.77TCr 56Cr 48Cr 46Cr 42Cr 78Cr 5.33TCr 78Cr 548.18Cr 211.54Cr 2.71TCr 208.79Cr 204.15Cr 8.72TCr
Net Debt -2.65TCr -83Cr -73Cr -69Cr -62Cr -116.74Cr -8TCr -117.23Cr -821.92Cr -317.18Cr -4.07TCr -313.05Cr -306.1Cr -13TCr -3.47TCr -109.11Cr -95Cr -90Cr -82Cr -152.85Cr -10TCr -153.49Cr -1.08TCr -415.27Cr -5.32TCr -409.87Cr -400.77Cr -17TCr
Logo PharmaEssentia Corporation
PHARMAESSENTIA CORPORATION is a Taiwan-based company primarily engaged in the research and development, clinical trials, manufacturing, sale, and marketing of innovative biotechnology drugs. It also oversees registration and marketing authorization applications based on product development progress. The Company focuses on hematology and oncology, utilizing the PEGylation technology platform for drug candidate design and development. The Company’s proprietary product, Ropeg, is used to treat polycythemia vera (PV), primarily sold in the United States.
Employees
131
Date Price Change Volume
20/26/20 NT$1,205.00 +2.12% 5,19,966
18/26/18 NT$1,180.00 -1.26% 1,27,20,966
17/26/17 NT$1,195.00 -0.83% 22,07,445
16/26/16 NT$1,205.00 0.00% 25,65,604
15/26/15 NT$1,205.00 +1.26% 23,15,449
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
1,205.00TWD
Average target price
1,397.26TWD
Spread / Average Target
+15.96%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. 6446 Stock
-40%: Exceptional extension
d
:
:
SEIZE THE OFFER!